Shantanu CEO
Our Story

About Allurion

Allurion Technologies

Allurion was founded in 2009 by Shantanu Gaur and Samuel Levy while they were studying at Harvard Medical School. Owing to their studies, Shantanu and Samuel started to rethink popular perceptions about weight loss. To better understand the journeys of people who were overweight or struggling with obesity, they did something quite unusual in modern day medicine: they started listening to their patients’ stories.

The two soon realised that ineffective diets were frustrating: their weight would return or they would struggle with the feeling of hunger and deprivation. It came as no surprise that many people were either afraid of traditional, invasive weight-loss surgery, or they simply could not afford the costly weight-loss solutions available.

Patients were seeking something easy and convenient—a treatment without the medical complexity that came with other weight-loss therapies. They expressed a desire for so much more than just a magic pill: they wanted a weight loss program that would empower them to make healthy choices that last a lifetime. They want to end obesity for good.

As Shantanu and Samuel started researching solutions, they imagined what has now become the Allurion Programme.

The Allurion Programme has already been used by thousands of people around the world and it is fast becoming a best-in-class solution.

Today, Allurion retains the original vision of its founders: to end obesity for good by catalyzing weight loss for life.

El médico ayuda a un paciente a perder peso

The Science

A new medical technology: backed by science and gets results.

With 100,000 Balloons distributed worldwide, Allurion is backed by clinical evidence and helps patients lose 10–15% of their body weight in just 16 weeks*.


Clinical Research

El médico sostiene el balón gástrico Allurion en su mano

The Procedureless Elipse Gastric Balloon Program: Multicenter Experience in 1770 Consecutive Patients.

A Doctor holding both the Allurion Gastric Balloon and Capsule in his hands

The Safety and Efficacy of Procedureless Gastric Balloon: a Study Examining the Effect of Elipse Intragastric Balloon Safety, Short and Medium Term Effects on Weight Loss with 1-Year Follow-Up Post-removal

Allurion Balloon

Effect of A New SwallowableIntragastric Balloon (Elipse™) on Weight Loss and Metabolic Syndrome

A Doctor holding the Allurion Gastric Capsule in his hands

The Efficacy and Safety of a Procedureless Gastric Balloon for Weight Loss: a Systematic Review and Meta-Analysis


Meet the Team

View page